when is her2-positive breast cancer most likely to recur

Release time ：Dec-19,2024

The likelihood of recurrence for Her2-positive breast cancer is typically highest within the first five years post-treatment, particularly in the first two to three years. During this time, cancer cells may become resistant to therapy, or recurrence may occur due to residual microtumors that were not entirely eradicated during treatment. Moreover, factors such as the patient's age, tumor size, lymph node involvement, and the presence of other health issues can influence the risk of recurrence. For instance, younger patients with larger tumors, lymph node involvement, and other health issues are at a higher risk of recurrence. Consequently, for individuals with Her2-positive breast cancer, regular follow-up exams and maintaining a healthy lifestyle are crucial. It is advised that patients with Her2-positive breast cancer undergo routine physical check-ups and breast cancer screenings to detect any potential recurrences early. Additionally, patients should adhere to their doctor's recommendations, complete their treatment plans on schedule, and engage in subsequent monitoring and management under medical supervision. Should any discomfort or concerns arise, they should promptly seek medical consultation.